Hernán Carranza
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 18
- Lung Cancer Diagnosis and Treatment 7
- Oncology 21
- Lung Cancer Research Studies 11
- Colorectal Cancer Treatments and Studies 6
- Cancer Immunotherapy and Biomarkers 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Andrés F. Cardona (35 shared papers)Carlos Vargas (25 shared papers)Óscar Arrieta (21 shared papers)Jorge Otero (27 shared papers)Luis Corrales (18 shared papers)Claudio Martín (16 shared papers)Rafael Rosell (14 shared papers)Roberto Sánchez-Reyes (2 shared papers)
In The Last Decade
Hernán Carranza
31 papers receiving 413 citations
Peers
Comparison fields: 5 of 63
- Oncology 245
- Pulmonary and Respiratory Medicine 280
- Cancer Research 117
- Molecular Biology 131
- Pathology and Forensic Medicine 25
Countries citing papers authored by Hernán Carranza
This map shows the geographic impact of Hernán Carranza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hernán Carranza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hernán Carranza more than expected).
Fields of papers citing papers by Hernán Carranza
This network shows the impact of papers produced by Hernán Carranza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hernán Carranza. The network helps show where Hernán Carranza may publish in the future.
Co-authors
The 25 scholars most cited alongside Hernán Carranza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 143 | |
| 2 | 2014 | 68 | |
| 3 | 2016 | 32 | |
| 4 | 2018 | 26 | |
| 5 | 2017 | 24 | |
| 6 | 2019 | 22 | |
| 7 | 2016 | 22 | |
| 8 | 2013 | 15 | |
| 9 | 2017 | 10 | |
| 10 | 2016 | 9 | |
| 11 | 2020 | 9 | |
| 12 | 2018 | 7 | |
| 13 | 2012 | 3 | |
| 14 | Pseudomyxoma peritonei: first cases treated by radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | 2009 | 3 |
| 15 | 1999 | 3 | |
| 16 | 2019 | 2 | |
| 17 | 2017 | 2 | |
| 18 | 2019 | 2 | |
| 19 | 2016 | 2 | |
| 20 | Pseudomixoma peritoneal: primeros casos tratados en Colombia con peritonectomía radical y quimioterapia intraperitoneal hipertérmica | 2009 | 1 |
About Hernán Carranza
Hernán Carranza is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Genetics and Epidemiology, having authored 36 papers that have together received 417 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (11 papers), Lung Cancer Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Peptidase Inhibition and Analysis (2 papers) and Case Reports on Hematomas (2 papers). The work is most often cited by research in Oncology (245 citations), Pulmonary and Respiratory Medicine (280 citations), Cancer Research (117 citations), Molecular Biology (131 citations) and Pathology and Forensic Medicine (25 citations). Hernán Carranza has collaborated with scholars based in Colombia, Mexico and Spain. Frequent co-authors include Andrés F. Cardona, Carlos Vargas, Óscar Arrieta, Jorge Otero, Luis Corrales, Claudio Martín, Rafael Rosell, Roberto Sánchez-Reyes, Alma D. Campos-Parra and July Rodríguez. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Targeted Oncology, Cancer and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.